Promega's Política de cookies

Empleamos cookies y tecnologías similares para mantener la funcionalidad de nuestro sitio web, analizar su rendimiento, mejorar el funcionamiento y mostrar contenido personalizado. Algunas cookies son esenciales para el buen funcionamiento de nuestro sitio web. El resto no serán instaladas en su equipo sin su consentimiento. Visite la Política de Cookies para obtener mayor detalle.

new-kit-box new-kit-box new-kit-box

Easily Screen and Profile LRRK2 Kinase Inhibitors

  • Includes kinase, substrate and reaction buffer
  • Use with ADP-Glo™ Assay for bioluminescent detection of kinase activity

Catalog Number:

Size

Additional options

Catalog Number: V4474

Consultar Precio

Catalog Number: V6442

Consultar Precio

Catalog Number: V4475

Consultar Precio


Overview
Protocols
Specifications
Resources
Related Products

Convenient, Scalable Kinase Profiling

The Kinase Enzyme Systems include a recombinant kinase enzyme, a substrate appropriate for the enzyme, a reaction buffer and supplemental reagents as needed. The LRRK2 Kinase Enzyme System contains:

  • LRRK2 Kinase, 10μg (Human, recombinant; amino acids 968–end). MW: ~210kDa.
  • LRRKtide (RLGRDKYKTLRQIRQ) Substrate.
  • Reaction Buffer, DTT.

Recombinant human LRRK2 (968–end) was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag. LRRK2 or leucine-rich repeat kinase is a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain and a WD40 domain. Mutations in LRRK2 are the most frequent known cause of autosomal dominant and idiopathic Parkinson's disease with prevalent mutations being found within the GTPase and kinase domains. LRRK2 cooperates with MET to promote efficient tumor cell growth and survival in various cancers. Downregulation of LRRK2 in cultured tumor cells compromises MET activation and selectively reduces downstream MET signaling to mTOR and STAT3.

LRRK2 NCBI Database Entry.

The LRRK2 Kinase Enzyme System can be purchased with or without the ADP-Glo™ Kinase Assay reagents. Used together, the ADP-Glo™ Kinase Assay + Kinase Enzyme Systems provide a convenient method for profiling the effect of lead compounds on kinase activity. Assay advantages include broad dynamic range, ease of use and high sensitivity. Kinase Enzyme Systems are manufactured by SignalChem. Bulk quantities available upon request.

Use with ADP-Glo™ Kinase Assay

The ADP-Glo™ Kinase Assay is a luminescent kinase assay that measures ADP formed from a kinase reaction; ADP is converted into ATP, which is a substrate in a reaction catalyzed by Ultra-Glo™ Luciferase that produces light. The luminescent signal positively correlates with ADP amount and kinase activity. The assay is well suited for measuring the effects of chemical compounds on the activity of a broad range of purified kinases, making it ideal for both primary screening as well as kinase selectivity profiling. The ADP-Glo™ Kinase Assay can be used to monitor the activity of virtually any ADP-generating enzyme (e.g., kinase or ATPase) using up to 1mM ATP.

 

See all Kinase Enzyme Systems available from Promega.

Specifications

Catalog Number:

Certificado de Análisis

Search by lot number

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Condiciones de Almacenaje

AA

Certificado de Análisis

Search by lot number

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Condiciones de Almacenaje

AA

Contenido

Item Part # Presentación
LRRK2 Kinase Enzyme System V4474 1 × 10μg

ADP-Glo™ Kinase Assay

V9101 1 × 1,000 assays

Certificado de Análisis

Search by lot number

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Patentes y Exclusiones

U.S. Pat. No. 7,700,310 and other patents and patents pending.

U.S. Pat. No. 8,183,007 and other patents and patents pending.